Common TitleStudy 118
Official Title A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Phase Phase III
ClinicalTrials.gov NCT01363011
Treatments
Atazanavir-Cobicistat
Atazanavir-Cobicistat
Tradename:EvotazOther Names:ATV-COBIClass:Protease Inhibitors (PI)Categories PharmacologyTreatment-ExperiencedSwitch/SimplificationAdverse Effects
Funding
IndustryGilead Sciences
References
- McDonald CK, Martorell C, Ramgopal M, et al. Cobicistat-boosted protease inhibitors in HIV-infected patients with mild to moderate renal impairment. HIV Clin Trials. 2014;15:269-73.